In consultation: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Consultation end date

Consultation end date

Type

Type

Guidance programme

Showing 1 to 2 of 2

TitleConsultationTypeConsultation end date
Anitocabtagene autoleucel for treating relapsed or refractory multiple myeloma ID6549Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Linvoseltamab for treating relapsed or refractory multiple myeloma after 3 or more treatments [ID6609]Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All